$SWAG
Stran & Company, Inc. Stock $swag

$swag Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023067066 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$19.30M	$17.47M
YoY Change	42.19%	17.99%
Cost Of Revenue	$12.93M	$12.39M
YoY Change	38.63%	12.19%
Gross Profit	$6.371M	$5.077M
YoY Change	50.01%	35.02%
Gross Profit Margin	33.01%	29.06%
Selling, General & Admin	$5.940M	$16.53M
YoY Change	21.31%	290.56%
% of Gross Profit	93.23%	325.57%
Research & Development		$1.163M
YoY Change
% of Gross Profit		22.91%
Depreciation & Amortization	$390.0K	$235.0K
YoY Change	108.17%	42.23%
% of Gross Profit	6.12%	4.63%
Operating Expenses	$5.940M	$6.351M
YoY Change	21.31%	50.07%
Operating Profit	$431.7K	-$1.274M
YoY Change	-166.51%	169.98%
Interest Expense	$220.0K	-$1.163M
YoY Change	1618.75%	-48337.25%
% of Operating Profit	50.96%
Other Income/Expense, Net	$460.9K	$128.0K
YoY Change	-315.77%	438.1%
Pretax Income	$892.6K	-$1.146M
YoY Change	-203.47%	134.1%
Income Tax	$208.0K	-$308.0K
% Of Pretax Income	23.3%
Net Earnings	$684.6K	-$838.3K
YoY Change	-199.49%	87.36%
Net Earnings / Revenue	3.55%	-4.8%
Basic Earnings Per Share	$0.04	-$0.05
Diluted Earnings Per Share	$0.04	-$0.05
COMMON SHARES
Basic Shares Outstanding	18.42M shares	18.42M shares
Diluted Shares Outstanding	18.52M shares	18.54M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.69M	$3.143M
YoY Change	-10.42%	-88.86%
Cash & Equivalents	$9.435M	$15.27M
Short-Term Investments	$10.26M	$10.28M
Other Short-Term Assets	$5.100M	$1.977M
YoY Change	295.73%	40.03%
Inventory	$6.903M	$5.821M
Prepaid Expenses
Receivables	$16.53M	$13.96M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$48.23M	$49.63M
YoY Change	18.54%	5.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.414M	$1.295M
YoY Change	75.72%	85.78%
Goodwill
YoY Change
Intangibles	$10.31M	$10.71M
YoY Change	88.91%	169.16%
Long-Term Investments		$6.466M
YoY Change		-97.21%
Other Assets		$972.0K
YoY Change		4140.84%
Total Long-Term Assets	$13.07M	$13.48M
YoY Change	83.38%	139.83%
TOTAL ASSETS
Total Short-Term Assets	$48.23M	$49.63M
Total Long-Term Assets	$13.07M	$13.48M
Total Assets	$61.30M	$63.11M
YoY Change	28.21%	20.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.860M	$13.94M
YoY Change	70.71%	679.25%
Accrued Expenses	$1.680M	$11.56M
YoY Change	65.04%	951.73%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$3.155M
YoY Change	-100.0%	1843.21%
Long-Term Debt Due	$3.080M	$3.190M
YoY Change	72.98%	99.54%
Total Short-Term Liabilities	$16.92M	$19.49M
YoY Change	156.49%	86.25%
LONG-TERM LIABILITIES
Long-Term Debt	$4.880M	$59.46M
YoY Change	121.73%	4691.35%
Other Long-Term Liabilities	$860.0K	$37.11M
YoY Change	59.34%	5854.59%
Total Long-Term Liabilities	$5.741M	$5.646M
YoY Change	109.5%	202.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.92M	$19.49M
Total Long-Term Liabilities	$5.741M	$5.646M
Total Liabilities	$22.67M	$25.14M
YoY Change	142.7%	103.88%
SHAREHOLDERS EQUITY
Retained Earnings	$235.3K	-$449.3K
YoY Change	30.3%	-151.72%
Common Stock	$38.40M	$1.855K
YoY Change	2071081.98%	-3.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$6.643M
YoY Change
Treasury Stock Shares
Shareholders Equity	$38.64M	$37.97M
YoY Change
Total Liabilities & Shareholders Equity	$61.30M	$63.11M
YoY Change	28.21%	20.14%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	$684.6K	-$838.3K
YoY Change	-199.49%	87.36%
Depreciation, Depletion And Amortization	$390.0K	$235.0K
YoY Change	108.17%	42.23%
Cash From Operating Activities	-$5.710M	-$7.969M
YoY Change	46.15%	-17.91%
INVESTING ACTIVITIES
Capital Expenditures	$130.0K	$592.0K
YoY Change	-180.96%	-680.85%
Acquisitions
YoY Change
Other Investing Activities	$30.00K	$1.000K
YoY Change	-100.3%
Cash From Investing Activities	-$100.0K	-$591.0K
YoY Change	-99.01%	479.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-20.00K	11.09M
YoY Change	-98.95%	-656.08%
NET CHANGE
Cash From Operating Activities	-5.710M	-7.969M
Cash From Investing Activities	-100.0K	-591.0K
Cash From Financing Activities	-20.00K	11.09M
Net Change In Cash	-5.830M	2.526M
YoY Change	-63.35%	-121.4%
FREE CASH FLOW
Cash From Operating Activities	-$5.710M	-$7.969M
Capital Expenditures	$130.0K	$592.0K
Free Cash Flow	-$5.840M	-$8.561M
YoY Change	55.88%	-10.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41038
	dei	Entity Registrant Name EntityRegistrantName	STRAN & COMPANY, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3297200
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2 Heritage Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600
	dei	Entity Address City Or Town EntityAddressCityOrTown	Quincy
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02171
	dei	Local Phone Number LocalPhoneNumber	800-833-3309
	dei	City Area Code CityAreaCode	800
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18420264	shares
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	15271199	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	15253756	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	10277690	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	9779355	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13958984	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14442626	usd
CY2023Q2	strn	Deferred Income Taxes DeferredIncomeTaxes	1542000	usd
CY2022Q4	strn	Deferred Income Taxes DeferredIncomeTaxes	841000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	5820887	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6867564	usd
CY2023Q2	us-gaap	Prepaid Taxes PrepaidTaxes	87459	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	87459	usd
CY2023Q2	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	695711	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	386884	usd
CY2023Q2	us-gaap	Security Deposit SecurityDeposit	1976439	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	910486	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	49630369	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	48569130	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1294568	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1000090	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10711939	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6272205	usd
CY2023Q2	strn	Right Of Use Asset Office Leases RightOfUseAssetOfficeLeases	1470140	usd
CY2022Q4	strn	Right Of Use Asset Office Leases RightOfUseAssetOfficeLeases	784683	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	12182079	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	7056888	usd
CY2023Q2	us-gaap	Assets Assets	63107016	usd
CY2022Q4	us-gaap	Assets Assets	56626108	usd
CY2023Q2	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	3186825	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	1809874	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	676036	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	324594	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3012379	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4051657	usd
CY2023Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	997008	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	608589	usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2290639	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	633148	usd
CY2023Q2	strn	Reward Program Liability RewardProgramLiability	8875000	usd
CY2022Q4	strn	Reward Program Liability RewardProgramLiability	6000000	usd
CY2023Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	291438	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	365303	usd
CY2023Q2	strn	Note Payable Wildman NotePayableWildman	162358	usd
CY2022Q4	strn	Note Payable Wildman NotePayableWildman	162358	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	19491683	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13955523	usd
CY2023Q2	strn	Long Term Wildman Contingent Earn Out Liability LongTermWildmanContingentEarnOutLiability	4883265	usd
CY2022Q4	strn	Long Term Wildman Contingent Earn Out Liability LongTermWildmanContingentEarnOutLiability	2845944	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	762946	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	460089	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5646211	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3306033	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18540834	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18540834	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18475521	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18475521	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	1855	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1848	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	38416582	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	38279151	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-449315	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1083553	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	37969122	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	39364552	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63107016	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56626108	usd
CY2023Q2	us-gaap	Revenues Revenues	17470106	usd
CY2022Q2	us-gaap	Revenues Revenues	14806904	usd
	us-gaap	Revenues Revenues	33246353	usd
	us-gaap	Revenues Revenues	27066487	usd
CY2023Q2	strn	Purchases Expenses PurchasesExpenses	10810268	usd
CY2022Q2	strn	Purchases Expenses PurchasesExpenses	9497551	usd
	strn	Purchases Expenses PurchasesExpenses	20833814	usd
	strn	Purchases Expenses PurchasesExpenses	17454167	usd
CY2023Q2	strn	Freight Expenses FreightExpenses	1582917	usd
CY2022Q2	strn	Freight Expenses FreightExpenses	1549163	usd
	strn	Freight Expenses FreightExpenses	2641665	usd
	strn	Freight Expenses FreightExpenses	2633965	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12393185	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11046714	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	23475479	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20088132	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	5076921	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	3760190	usd
	us-gaap	Gross Profit GrossProfit	9770874	usd
	us-gaap	Gross Profit GrossProfit	6978355	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6351174	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4232170	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12430269	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8256388	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	6351174	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	4232170	usd
	us-gaap	Operating Expenses OperatingExpenses	12430269	usd
	us-gaap	Operating Expenses OperatingExpenses	8256388	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1274253	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-471980	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2659395	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1278033	usd
CY2023Q2	us-gaap	Other Income OtherIncome	15092	usd
CY2022Q2	us-gaap	Other Income OtherIncome	-23781	usd
	us-gaap	Other Income OtherIncome	71729	usd
	us-gaap	Other Income OtherIncome	-27461	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	146177	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6108	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	284259	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	92972	usd
CY2023Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-33303	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	98582	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	127966	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17673	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	454570	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	65511	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1146287	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-489653	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2204825	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1212522	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-307957	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-42210	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-671957	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-219265	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-838330	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-447443	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1532868	usd
	us-gaap	Net Income Loss NetIncomeLoss	-993257	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18540834	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19971552	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18540834	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19971552	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41611619	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1307362	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	100000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	118692	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-545814	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	42591859	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	48291	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1993610	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-447443	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	40199097	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	39364552	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	27383	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-694538	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	38697397	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	110055	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-838330	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	37969122	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1532868	usd
	us-gaap	Net Income Loss NetIncomeLoss	-993257	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-701000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-273700	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	654038	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	309482	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-67712	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-46561	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	110049	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	166983	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	98582	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-483642	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2354665	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1046677	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	727349	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	308827	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	10807	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-1065953	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-4097	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1039278	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3195114	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	388419	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-56930	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1657491	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	904537	usd
	us-gaap	Increase Decrease In Customer Loyalty Program Liability IncreaseDecreaseInCustomerLoyaltyProgramLiability	2875000	usd
	us-gaap	Increase Decrease In Customer Loyalty Program Liability IncreaseDecreaseInCustomerLoyaltyProgramLiability	3875000	usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	-73865	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1525376	usd
CY2023Q2	us-gaap	Property Plant And Equipment Owned Gross PropertyPlantAndEquipmentOwnedGross	62424	usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	164637	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2327231	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2241841	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	741109	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	540290	usd
	strn	Additions To Property And Equipment AdditionsToPropertyAndEquipment	-578792	usd
	strn	Additions To Property And Equipment AdditionsToPropertyAndEquipment	-189543	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	403524	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1723425	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-729833	usd
	strn	Contingent Earn Out Liabilities ContingentEarnOutLiabilities	586363	usd
	strn	Contingent Earn Out Liabilities ContingentEarnOutLiabilities	366840	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1993610	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1307362	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-586363	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1053088	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17443	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4024762	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15253756	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32226668	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15271199	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28201906	usd
	us-gaap	Interest Paid Net InterestPaidNet	3731	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	29043	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	76073	usd
	strn	Non Cash Premier Asset Acquisition NonCashPremierAssetAcquisition	1735000	usd
	strn	Non Cash Asset Acquisition NonCashAssetAcquisition	4551095	usd
	strn	Reduction In Contingent Earnout Liabilities ReductionInContingentEarnoutLiabilities	550460	usd
	strn	Reduction In Contingent Earnout Liabilities ReductionInContingentEarnoutLiabilities	70406	usd
	strn	Reduction In Intangible Asset Associated With Contingent Earnout Liabilities ReductionInIntangibleAssetAssociatedWithContingentEarnoutLiabilities	-550460	usd
	strn	Reduction In Intangible Asset Associated With Contingent Earnout Liabilities ReductionInIntangibleAssetAssociatedWithContingentEarnoutLiabilities	-70406	usd
CY2022Q4	us-gaap	Property Plant And Equipment Owned Gross PropertyPlantAndEquipmentOwnedGross	62424	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2673651	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2094859	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1379083	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1094769	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">8.</td><td style="text-align: justify">Concentration of Credit Risk - Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of accounts receivable and deposits in excess of federally insured limits. These risks are managed by performing ongoing credit evaluations of customers’ financial condition and by maintaining all deposits in high quality financial institutions.</td></tr></table>
	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">20.</td><td style="text-align: justify">Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.</td></tr></table>
CY2023Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	10421465	usd
CY2023Q2	strn	Unrealized Gain Loss On Investment UnrealizedGainLossOnInvestment	-143775	usd
CY2023Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	10277690	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	9958475	usd
CY2022Q4	strn	Unrealized Gain Loss On Investment UnrealizedGainLossOnInvestment	-179120	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	9779355	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1294568	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1000090	usd
CY2023Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5664	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	263907	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	264160	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5474007	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6557040	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	346880	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	310524	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	5820887	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6867564	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5664	usd
CY2023Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	536172	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	501395	usd
CY2023Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	2069391	usd
CY2023Q2	strn	Cost Of Sale Purchases CostOfSalePurchases	2409903	usd
CY2022Q4	strn	Cost Of Sale Purchases CostOfSalePurchases	3571942	usd
CY2023Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	602476	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	479715	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3012379	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	4051657	usd
CY2023Q2	us-gaap	Line Of Credit LineOfCredit	7000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	7000000	usd
CY2023Q2	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	0	usd
CY2022Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	0	usd
CY2023Q2	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.05	pure
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0875	pure
CY2022	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.08	pure
	us-gaap	Deferred Revenue Refund Payments1 DeferredRevenueRefundPayments1	2290639	usd
CY2022	us-gaap	Deferred Revenue Refund Payments1 DeferredRevenueRefundPayments1	633148	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	633148	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	721608	usd
	strn	Revenue Recognized RevenueRecognized	-33246353	usd
CY2022	strn	Revenue Recognized RevenueRecognized	-58953467	usd
	strn	Amounts Collected Or Invoiced AmountsCollectedOrInvoiced	34903844	usd
CY2022	strn	Amounts Collected Or Invoiced AmountsCollectedOrInvoiced	58865007	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	2290639	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	633148	usd
CY2023Q2	us-gaap	Deposit Liability Current DepositLiabilityCurrent	8875000	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	6000000	usd
CY2023Q2	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	162358	usd
CY2023Q2	strn	Amount Accrues No Interest AmountAccruesNoInterest	162358	usd
CY2023Q2	strn	Working Capital WorkingCapital	1123072	usd
CY2023Q2	strn	Intangible Customer List IntangibleCustomerList	5551095	usd
CY2023Q2	us-gaap	Asset Acquisition Consideration Transferred Other Assets AssetAcquisitionConsiderationTransferredOtherAssets	6674167	usd
CY2023Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	2123072	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4551095	usd
CY2023Q2	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	6674167	usd
CY2023Q2	strn	Right Of Use Assets RightOfUseAssets	1470140	usd
CY2022Q4	strn	Right Of Use Assets RightOfUseAssets	784683	usd
CY2023Q2	strn	Right Of Use Asset Office Leases Current RightOfUseAssetOfficeLeasesCurrent	676036	usd
CY2022Q4	strn	Right Of Use Asset Office Leases Current RightOfUseAssetOfficeLeasesCurrent	324594	usd
CY2023Q2	strn	Right Of Use Asset Office Leases Non Current RightOfUseAssetOfficeLeasesNonCurrent	762946	usd
CY2022Q4	strn	Right Of Use Asset Office Leases Non Current RightOfUseAssetOfficeLeasesNonCurrent	460089	usd
CY2023Q2	strn	Operating Leases OperatingLeases	1438981	usd
CY2022Q4	strn	Operating Leases OperatingLeases	784683	usd
CY2023Q2	us-gaap	Prepaid Rent PrepaidRent	220712	usd
CY2022Q2	us-gaap	Prepaid Rent PrepaidRent	221901	usd
CY2023Q2	strn	Operating Leases Future Minimum Payment Due Current OperatingLeasesFutureMinimumPaymentDueCurrent	501393	usd
CY2023Q2	strn	Operating Leases Future Minimum Payment Due In Two Years OperatingLeasesFutureMinimumPaymentDueInTwoYears	482074	usd
CY2023Q2	strn	Operating Leases Future Minimum Payment Due In Three Years OperatingLeasesFutureMinimumPaymentDueInThreeYears	187115	usd
CY2023Q2	strn	Operating Leases Future Minimum Payment Due In Four Years OperatingLeasesFutureMinimumPaymentDueInFourYears	190854	usd
CY2023Q2	strn	Operating Leases Future Minimum Payment Due In Five Years OperatingLeasesFutureMinimumPaymentDueInFiveYears	161960	usd
CY2023Q2	strn	Operating Lease Future Minimum Payments Due OperatingLeaseFutureMinimumPaymentsDue	1523396	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1	shares
	strn	Warrants Outstanding WarrantsOutstanding	4478134	shares
	strn	Warrants Outstanding WarrantsOutstanding	4478134	shares
CY2021Q4	strn	Outstanding Voting Stock Percentage OutstandingVotingStockPercentage	0.654	pure
CY2022Q1	strn	Private Placement Exercise Price PrivatePlacementExercisePrice	1
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10345784	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.9
	strn	Weighted Average Life Years Beginning Balance WeightedAverageLifeYearsBeginningBalance	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	271589	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.81
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10074195	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.91
	strn	Weighted Average Life Years Beginning Balance WeightedAverageLifeYearsBeginningBalance	P5Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10074195	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.91
	strn	Weighted Average Life Years Beginning Balance WeightedAverageLifeYearsBeginningBalance	P4Y
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10074195	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.91
	strn	Weighted Average Life Years Beginning Balance WeightedAverageLifeYearsBeginningBalance	P4Y
CY2022Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	10000000	usd
CY2023Q2	us-gaap	Shares Issued SharesIssued	1777657	shares
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.87
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1777657	shares
	strn	Stock Issued During Periods Value New Issue StockIssuedDuringPeriodsValueNewIssue	6667595	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	137438	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	166983	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Description ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription	Option awards are generally granted with an exercise price equal to the fair value of the Company’s stock at the date of grant; those options generally vest based on four years of continuous service and have 10-years contractual terms.
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0358	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2924	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1587000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.15
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	3045700	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	61000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.8
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	10000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.15
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1638000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.06
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	94850	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.97
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1558000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.17
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	15000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.77
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	25834	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.29
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1547167	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.14
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	593063	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.1
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.8
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.77
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10Y
	us-gaap	Net Income Loss NetIncomeLoss	-1532868	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18540834	shares
	us-gaap	Net Income Loss NetIncomeLoss	-993257	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19971552	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1532868	usd
	us-gaap	Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma	18540834	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-993257	usd
	us-gaap	Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma	19971552	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	strn	Warrants To Purchase WarrantsToPurchase	10074195	shares
	strn	Warrants To Purchase WarrantsToPurchase	453918	shares
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	48282	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-503000	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-203700	usd
	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-503000	usd
	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-155418	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	29044	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6153	usd
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-198000	usd
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-70000	usd
	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-168956	usd
	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-63847	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-671956	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-219265	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	3114000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	174400	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	1542000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	386700	usd
	us-gaap	Advertising Expense AdvertisingExpense	306990	usd
	us-gaap	Advertising Expense AdvertisingExpense	87067	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18540834	shares
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q2	us-gaap	Other Long Term Debt OtherLongTermDebt		usd
CY2022Q4	us-gaap	Other Long Term Debt OtherLongTermDebt		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
	strn	Weighted Average Life Years WeightedAverageLifeYears
	strn	Weighted Average Life Years Warrants Exercised WeightedAverageLifeYearsWarrantsExercised
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
	strn	Weighted Average Life Years WeightedAverageLifeYears
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
	strn	Weighted Average Life Years Warrants Exercised WeightedAverageLifeYearsWarrantsExercised
	strn	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted		usd
	strn	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited Or Expired And Other Adj SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeitedOrExpiredAndOtherAdj		usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	strn	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted		usd
	strn	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited Or Expired And Other Adj SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeitedOrExpiredAndOtherAdj		usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Stock Dividends Shares StockDividendsShares		shares
	us-gaap	Stock Dividends Shares StockDividendsShares		shares
	us-gaap	Stock Dividends Shares StockDividendsShares		shares
	us-gaap	Stock Dividends Shares StockDividendsShares		shares
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001872525

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001213900-23-067066-index-headers.html	Edgar Link	pending
0001213900-23-067066-index.html	Edgar Link	pending
0001213900-23-067066.txt	Edgar Link	pending
0001213900-23-067066-xbrl.zip	Edgar Link	pending
f10q0623ex31-1_stran.htm	Edgar Link	pending
f10q0623ex31-2_stran.htm	Edgar Link	pending
f10q0623ex32-1_stran.htm	Edgar Link	pending
f10q0623ex32-2_stran.htm	Edgar Link	pending
f10q0623_stranandco.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
f10q0623_stranandco_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
strn-20230630.xsd	Edgar Link	pending
strn-20230630_cal.xml	Edgar Link	unprocessable
strn-20230630_def.xml	Edgar Link	unprocessable
strn-20230630_pre.xml	Edgar Link	unprocessable
strn-20230630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SWAG
Stran & Company, Inc. Stock $swag

2023 Q3 Form 10-Q Financial Statement

#000121390023067066 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWAG Stran & Company, Inc. Stock $swag

2023 Q3 Form 10-Q Financial Statement

#000121390023067066 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWAG
Stran & Company, Inc. Stock $swag